Proton Therapy MarketSize and Trends

The global proton therapy market is estimated to be valued at US$ 2,763.2 Mn in 2023 and is expected to exhibit a CAGR of 13.0% during the forecast period (2023-2030).

Figure 1. Global Proton Therapy Market Share (%), by Set up Type, 2023

The global proton therapy market report is segmented into by Set up Type, by Indication, and Region.

By Set up Type, the market is segmented into single room and multi room. Out of which, single room segment is expected to hold a dominant position in the global proton therapy market during the forecast period and this is attributed to the low cost of single room proton therapy as compared to multiple room proton therapy.

By Indication the market is segmented into Head & Neck Cancer, Brain Cancer, Sarcoma, Pediatric Cancer, Gastro-intestinal Cancer, Prostate Cancer, and Lung Cancer. Out of which, the lung cancer segment is expected to hold a dominant position in the global proton therapy market during the forecast period and this is attributed to the increasing prevalence of lung cancer.

By Region, North America is expected to dominate the market over the forecast period and this is attributed to the increasing prevalence of cancer and geriatric patients. The increasing prevalence of cancer is expected to drive the market over the forecast period.

Among all the segmentations, the set up type segment has the highest potential due to the increasing prevalence of cancer over the forecast period. For instance, in February 2022, according to the WHO (World Health Organization), cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020 (1). The most common in 2020 (in terms of new cases of cancer) were: breast (2.26 million cases); lung (2.21 million cases); colon and rectum (1.93 million cases); prostate (1.41 million cases); skin (non-melanoma) (1.20 million cases); and stomach (1.09 million cases).

Global Proton Therapy Market: Key Trends

High need for proton therapy, key market players increasing their footprint in developing nations

Rising demand of proton therapy, key players are focusing on collaboration as well as acquisition by expanding their presence in emerging such as Africa, Asia, etc., economies is expected to experience considerable expansion in global proton therapy market. For instance, in August 2022, IBA Radiopharma Solutions, a medical technology company and provider of proton therapy solutions for the treatment of cancer, announced it had signed a collaboration agreement with Apollo Hospitals Enterprise Ltd (AHEL), to provide proton therapy training and education programs for IBA customers in Asia-India.